Sinan Ahmed D. Dheyauldeen

  • Consultant MD, PhD
 

Publications 2018

Eguíluz-Gracia I, Malmstrom K, Dheyauldeen SA, Lohi J, Sajantila A, Aaløkken R, Sundaram AYM, Gilfillan GD, Makela M, Baekkevold ES, Jahnsen FL (2018)
Monocytes accumulate in the airways of children with fatal asthma
Clin Exp Allergy, 48 (12), 1631-1639
DOI 10.1111/cea.13265, PubMed 30184280

Steineger J, Osnes T, Heimdal K, Dheyauldeen S (2018)
Long-term experience with intranasal bevacizumab therapy
Laryngoscope, 128 (10), 2237-2244
DOI 10.1002/lary.27147, PubMed 29469958

Steineger J, Ueland T, Aukrust P, Michelsen A, Osnes T, Heimdal K, Dheyauldeen S (2018)
Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis
Laryngoscope, 129 (1), E44-E49
DOI 10.1002/lary.27548, PubMed 30329172

Publications 2017

Dollner R, Lorentz Larsen P, Dheyauldeen S, Steinsvåg S (2017)
A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu
Allergy Rhinol (Providence), 8 (3), 148-156
DOI 10.2500/ar.2017.8.0216, PubMed 29070272

Steineger J, Merckoll E, Slåstad JM, Eriksen EF, Heimdal K, Dheyauldeen S (2017)
Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report
Laryngoscope, 128 (3), 593-596
DOI 10.1002/lary.26722, PubMed 28671294

Publications 2016

Eguíluz-Gracia I, Bosco A, Dollner R, Melum GR, Lexberg MH, Jones AC, Dheyauldeen SA, Holt PG, Bækkevold ES, Jahnsen FL (2016)
Rapid recruitment of CD14(+) monocytes in experimentally induced allergic rhinitis in human subjects
J Allergy Clin Immunol, 137 (6), 1872-1881.e12
DOI 10.1016/j.jaci.2015.11.025, PubMed 26851967

Publications 2012

Dheyauldeen S, Østertun Geirdal A, Osnes T, Vartdal LS, Dollner R (2012)
Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose
Laryngoscope, 122 (6), 1210-4
DOI 10.1002/lary.23303, PubMed 22565282

Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012)
Living with hereditary haemorrhagic telangiectasia: coping and psychological distress - a cross-sectional study
Disabil Rehabil, 35 (3), 206-13
DOI 10.3109/09638288.2012.690500, PubMed 22671535

Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K (2012)
Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study
Am J Med Genet A, 158A (6), 1269-78
DOI 10.1002/ajmg.a.35309, PubMed 22529055

Publications 2011

Dheyauldeen S, Abdelnoor M, Bachmann-Harildstad G (2011)
The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study
Am J Rhinol Allergy, 25 (4), 214-8
DOI 10.2500/ajra.2011.25.3616, PubMed 21819756

Publications 2010

Fodstad P, Dheyauldeen S, Rinde M, Bachmann-Harildstad G (2010)
Anti-VEGF with 3-week intervals is effective on anemia in a patient with severe hereditary hemorrhagic telangiectasia
Ann Hematol, 90 (5), 611-2
DOI 10.1007/s00277-010-1063-5, PubMed 20824275

Page visits: 521